rev:    5/16/2008

Return (Index/Home Page)

for recombinant cytokines and antibodies , click here

Return (Cytokine Kit information)


Sample Kit Protocol: (see actual insert with kit for batch specific information):


Pelikine Compact Human IL-I BETA ELISA Kit


CAT# RDI-M1934clb, new cat#: 55R-M1934clb   288 tests     PRICE: $525.00

-see insert with each kit for batch specific information


INTRODUCTION

Interleukin 1 (IL-1) refers to two polypeptide hormones, interleukin-1a (IL-1a) and interleukin-1B (IL-1B), that possess a wide spectrum of inflammatory, metabolic, physiological, haematopoietic and immunological activities. Although the two forms of IL-1 are distinct gene products, they recognize the same receptor and share biological properties. Several substances originally described for their biological activities have been identified as IL-1; catabolin, endogenous pyrogen (EP), osteoclastactivating factor (OAF), epidermal cell-derived thymocyte-activating factor(ETAF), serum amyloid A inducer or hepatocyte-stimulating factor (HSF), leucocyte endogenous mediator (LEM), fibroblast-activating factor (FAF), B-cell-activating factor (BAF), proteolysis-inducing factor (PIF), haemopoeitin-1 (H-1), mononuclear cell factor (MCF), lymphocyte proliferation promoting factor of neutrophils,melanoma growth inhibition factor and tumor inhibitory factor 2.

The biological properties of IL-1 shows considerable overlap with other cytokines, including tumour necrosis factor (TNF) and interleukin 6 (IL-6). They all share the ability to stimulate T and B lymphocytes, to augment cell proliferation and to initiate or suppress gene expression for several proteins. Elevated levels of circulating IL-1 have been repported in patients with renal allograft rejection, acute attacks of rheumatoid arthritis, alcoholic hepatitis and burns. In patients undergoing routine haemodialysis, several studies have shown elevations in plasma IL-1 levels 3-4 hours following the initliation of the procedure. IL-1 has also been detected in synovial fluid of patients with rheumatic arthritis and in cerebrospinal fluid of patients with closed head trauma and meningitis. In addition elevated IL-1levels were found in peritoneal, gingival, middle ear, ocular and nasal fluids of patients with various disease conditons. Bioassays for the quantification of IL-1a or IL-1B, based on the induction of IL-2 production by T-cell lines or proliferation of T-cell lines have been used for several years. These assays, although sensitive, are time consuming and might be susceptible to interference by other substances.This PeliKine compact (tm) IL-1B ELISA has been developed for faster, more reproducible and specific quantification of human IL-1B (huIL-1B) in serum and  culture supernatant.


II. PRINCIPLE OF THE TEST

The Pelikine compact human IL-1B ELISA kit is a "sandwich-type" of enzyme immumoassay in which a monoclonal anti-human IL-1B antibody is bound onto polystyrene microtiter wells. Human IL-1 B present in a measured volume of sample or standard is captured by the antibody on the microtiter plate, and non-bound material is removed by washing.Subsequently, a biotinylated second monoclonal antibody to huIL-1B is added. This antibody binds to the huIL-1B -antibody complex present in the microtiter well. Excess biotinylated antibody is removed by washing, followed by addition of horseradish peroxidase (HRP) conjugated streptavidin, which binds onto the biotinylated side of the huIL-1B sandwich. After removal of non-bound HRP conjugate by washing, a substrate solution is added to the wells. A colored product is formed in proportion to the amount of huIL-1B present in the sample or standard. After the reaction has been terminated by the addition of a stop solution, absorbance is measured in a microtiter plate reader. From the absorbance of samples and those of a standard curve, the concentration of huIL-1B can be determined by interpolation with the standard curve.


III. STORAGE AND STABILITY

The Pelikine compact human IL-1B ELISA kit should be stored at 18'C to -32'C. The performance of the kit is guaranteed until the expiration date shown on the case label.


IV. CONTENTS OF THE KIT

The Pelikine compact human IL-1B ELISA kit contains material sufficient for 288 tests, including standard curve samples. The reagents provided are:

Quantity              Kit Component                                                           Volume              Cap color

1 vial                   coating antibody  100-fold concentrated                     375ul                 red

1 vial                   blocking reagent 50-fold concentrated                           2ml                 transparent

  vial                   IL-1B standard (lyophilzed)                                     

1 vial                   biotinylated IL-1B antibody 100-fold concentrated   375ul            yellow

1 vial                   streptavidin-HRP conjugate 10,000-fold concentrated   20ul               brown

1 bottle                dilution buffer 5-fold concentrated                                60ml

3 pcs                    microtiter plastes + lid

10 pcs                  plate seals


V. PRECAUTIONS FOR USE

1) The compact IL-1B ELISA kit is intended for research purposes   only.

2) Only use the reagents and microtiter plates supplied with the   kit, do not mix reagents from different kit lots.

3) Handle all plasma and serum samples with care to prevent transmission of blood-borne infections.

4) Sodium azide inactivates HRP, do not use sodium azide-contain ing solutions, nor add sodiium azide to the supplied materials

5) All reagents contain thiomersal (0.001 % w/v) and may be toxic upon ingestion, inhalation or skin contact. Avoid contact of   skin, eyes or clothing with dilution, washing or substrate buffer.In case of contact, wash skin or eyes with water and consult a physician.

6) Centrifuge all vials before use (1 minute 3000 x g).

7) With the exception of the substrate blank wells, do not allow wells to stand uncovered or dry for extended periods between incubation steps.


VI. ADDITIONAL BUFFERS & SOLUTIONS REQUIRED

Coating buffer: 0.1M Carbonate/bicarbonate buffer pH 9.6

    Solution A: 1.24 g Na2CO3.H2O in 100 ml distilled water

    Solution B: 1.68 g NaHCO3 in 200 ml distilled water

Take 70ml of solution A, and add solution B until the pH is 9.6 (approximately 175 ml of solution B required).

The prepared buffer can be stored up to one week at 2-8'C.


PBS stock solution [20 x]: 0.2 M Phosphate Buffered Saline (PBS)

Dissolve 32 g   Na2HPO4.2H20

                 6 g   NaH2PO4.2H20

             164 g   NaC1

in 900 ml distilled water

(intensive stirring and some heating will speed dissolution). Bring temperature to room temperature (18-25'C) and check pH; if necessary adjust pH to 6.8 - 6.9 with concentrted HC1 or NaOH, and add distilled water to a volume of 1 liter (when diluted 20 times the obtained buffer will have a pH of 7.2 -7.4). Add 20 mg thiomersal as preservative. Do not use sodium azide (NaN3) since this preseervative reduces the quality of the enzymatic label.

The prepared buffer can be stored up to three months at 2-8'C.

Note: in the concentrated buffer salt crytals may appear when stored at 2-8'C. Before preparing the working-strength buffer, first warm the concentrated buffer BRIEFLY to 37'C to dissolve the precipitate.


Washing buffer: PBS with 0.005 % TWEEN 20

Make 1 liter of working-strength PBS by diluting the PBS stock  solution (see above) 20-fold with distilled water.

Add 50 ul TWEEN 20.

The prepared buffer can be stored up to one month at 2-8'C.


Substrate buffer: 0.11 M acetate buffer pH 5.5

Dissolve 15.0 g sodium-acetate (CH3COONa.3H20) in 800 ml dis tilled water.

Adjust pH to 5.5 with glacial acetic acid, add distilled water   to a volume of 1 liter.

Do not add any preservative (e.g. merthiolate,sodium azide) since this may affect the quality of the enzymatic color dev elopment.   The prepared buffer can be stored up to two weeks at 2-8'C.


3,5,3',5'-tetramethylbenzidine (TMB) stock solution: 6mg/ml TMB   in DMSO

Dissolve 30 mg 3,5,3',5'-tetramethylbenzidine (TMB) in 5 ml dimethylsulfoxide (DMSO).

The prepared stock solution can be stored up to 1 month at room temperature (18-25'C) and protected against light.


Hydrogen peroxide stock solution: 3% H202 solution in distilled water.

The prepared stock solution can be stored up to one month at  2-8'C.


Substrate solution

For each plate mix the following reagents:

    12 ml Substrate buffer

   200 ul TMB stock solution

    12 ul H202 stock solution

The substrate solution should be prepared just before use and has to be at room temperature (18-25'C) for optimal reproducible results.


Stop solution: 1.8 M H2S04 solution in distilled water.


VII. ADDITIONAL INFORMATION

Additional materials required

-Pipetting devices for accurate delivery of 1-10ul, 50 ul, 100 ul and 1 ml volumes.

-Beakers, flasks, cylinders necessary for preparation of reagents.

-Device for delivery of washing buffer(wash bottle/automated plate washer).

-Microtiter plate reader.


Sensitivity

MEAN calculated zero signal + 3 SD :  0.8-1.5 pg/ml(shake-static incubation)

2 x(MEAN calculated zero signal):       2.5-4.0 pg/ml(shake-static incubation).

Note: the sensitivity is dependent of the type and quality of enzymatic substrate.


Expected values

IL-1B values in fresh serum,plasma and urine samples of healthy individuals are below 5 pg/ml.


Specificity

No crossreactivity was observed with the following recombinant human proteins: IL-1a, IL-2,IL-3,IL-4,IL-5,IL-6,IL-7,IL-8 IL-9,IL-11,IL-13, Macrophage Colony Stimulating Factor (M-CSF), Granulocyte Colony Stimulating Factor (G-CSF). Granulocyte/Macrophage Colony Stimulating Factor (GM-CSF), Leukaemia Inhibitory Factor (LIF),RANTES, Stem Cell Factor/Mast Cell Factor (SCF/MCF), Transforming Growth Factor B-1 (TGFB-1),Tumor Necrosis Factor a (TNFa) and Tumor Necrosis Factor B (TNFb/Lymphotoxin),and Interferon G (IFNg).


REFERENCES

1. Aggerwal,B.B. Gutterman,J.U. (1992) Human cytokines. Blackwell Sci.Pub.ISBN 0-86542-183-8.

2. Ben-Aribia,M.H. et al (1987) J.Immunol. 139:443.

3. Bodel P.T. et al (1968) Br.J.Exp. Pathol. 49:11.

4. Clowes,G.J.A. et al (1983) N.Engl. J. Med. 308:545.

5. Dinarello,C.A., et al (1986) J. Clin.Invest. 77: 1734.

6. Dinarello, C.A. (1989) Adv. Immunol. 44: 153.

7. Eastgate, J.A. et al (1988) Lancet 2: 706.

8. Eisenberg, J.A. et al (1990) Nature 343:341.

9. Falkoff, F,J. et al (1984) J. Immunol. 133: 443.

10.Gahring,L.C. (1984) Fed. Proc. 43: 462.

11.Gery, L. et al (19732) J. Exp.Med. 136: 128.

12.Gray, P.W. et al (1986) J. Immunol. 137: 3644.

13.Hannum, C.H. et al (1990) Nature 343: 336.

14.Jasin, H.E. Dingle,J.T. (1981) J.Clin.Invest. 68:571.

15.March,C.J. et al (1985) Nature 315: 641.

16.Oppenheim J.J. et al (1986) Immunol. Today 7:45.

17.Porat, R. et al (1991) Science 254: 430.

18.Thomson,A.W. (1991) The cytokine handbook. Academic Press ISBN 0-12-689660-7.


VIII. ASSAY PROCEDURE

1. BRING ALL REAGENTS TO ROOM TEMPERATURE (18-25'C), with the exception of the streptavidin-HRP conjugate which has to be kept at -18'C to -32'C to ensure stability. Centrifuge all vials before use (1 minute 3000 x g).

For your convenience an easy-reference manual with check list   and plate plan are available on the last pages of this leaflet


2. DILUTION BUFFER

The kit contains one bottle with 5-fold concentrated dilution buffer.

For optimal assay results, dilute samples and standard in working-strength dilution buffer.

Calculate the quantity of dilution buffer required (approximately 15 ml undiluted buffer per microtiter plate) and prepare a working-strength solution by diluting the opalescent concentrated buffer 5 times in distilled water before use. The working-strength dilution buffer can be stored for up to one week at 2-8'C.

3. MICROTITER PLATES Coating antibody   Coating

The kit contains three microtiter plates for 96 tests each,in cluding the standard curve samples.

Prepare coating buffer as described on page 3 of the information  leaflet.

Per microtiter plate, add 120 ul of coating antibody (red-capped vial) to 12 ml coating buffer.

Add 100 ul to all wells, cover microtiter plate(s) with lid and incubate overnight at room temperature (18-25'C).

Washing procedure

Prepare working-strength PBS (1:20 dilution of stock PBS as described on page 3 of the information leaflet).

Aspirate supernatants from wells and completely fill the wells (>300 ul) with working-strength PBS and aspirate. Repeat this four times, after the final aspiration the wells should be dry.

Blocking procedure

The kit contains one transparent-capped vial with 2 ml blocking  reagent.


Prepare blocking buffer by adding 500 ul blocking reagent to 25 ml working-strength PBS (1:20 dilution of stock PBS as described on page 3 of the information leaflet). Add 200 ul blocking buffer to all wells, cover microtiter plate(s) with adhesive seal,gently agitate the microtiter plate by tapping the edge of the plate for a few seconds to mix contents of each well and incubate for 1 hour at room temperature (18-25'C).

4.IL-1B STANDARD Standard curve preparation

A natural human IL-1B standard  .The kit contains one lyophilized vial with natural IL-1B. Reconstitute the lyophilized standard by adding  (see kit insert) ul of distilled water to the vial. Incubate for 10 minutes at room temperature and mix gently. After reconstitution the standard must   be kept cold (2-8'C) and stored frozen after use (<-18'C, preferably <-70'C).

Label 7 tubes, one tube for each dilution:300, 120, 33, 11, 3.6, 1.2, and 0.4pg/ml. Pipette 450 ul of working-strength dilution buffer into the tube labelled 300 pg/ml and 300 ul of working-strength dilution buffer into the other tubes. Transfer 50 ul of the IL-1B standard (3000 pg/ml into the first tube labelled 300pg/ml, mix well and transfer 150ul of this dilution into the second tube labelled 100 pg/ml. Repeat the serial dilutions six more times by adding 150ul of the previous tube of diluted standard to the 300 ul of dilution buffer.

The standard curve will contain 300, 100, 33, 11, 3.6 , 1.2, 0.4 and 0 pg/ml (dilution buffer). It is recommended to prepare two separate series for each assay.

Avoid repeated freeze-thawing of the standard, although experimental data have shown that up to 3 freeze-thaw cycles have no effect on the IL-1B levels of the standard. Thaw the reconstituted standard in tap water (18-24'C), do not use 37'C or 56'C water baths for this purpose. The second vial of standard can be used in case of prolonged storage of the reconstituted standard (>2 months).

5. SAMPLES

Serum, EDTA-anti-coagulated plasma, and culture fluids are suitable for use in the assay (caution: separate plasma/serum and blood cells within 4 hours after collection, non-separated samples must be kept on temperatures from 2 to 8'C). Do not use grossly haemolyzed or lipemic specimens. If rheumatoid factors are expected in serum or plasma samples, it is recommended to add normal mouse serum (CLB cat#M1250, final concentration in the diluted sample should be 5%).If samples are to be run within 24 hours, they may be stored at 2-8'C; otherwise samples should be stored frozen (<-18'C). Up to 3 freeze-thaw cycles have no effect on the IL-1B levels of serum or plasma samples. Prior to the assay,frozen samples should be thawed as quickly as possible in a 37'C waterbath and then brought to room temperature (18'-25'C).

It is recommended to dilute the test samples at least 1:2 in working-strength dilution buffer. If high levels of IL-1B (>100pg/ml) are expected in the test samples, additional dilutions of sample i.e. 1:10 and 1:100 should also be prepared.

6. FIRST WASH STEP

Prepare washing buffer as described on page 3 of this leaflet.

Wash the required microtiter plates five times with washing buffer in a plate washer. In case of manual washing,completely fill the wells (>300ul) with washing buffer and aspirate,repeat this four times. After the final aspiration the wells should be dry.

7. FIRST INCUBATION STEP Standards and samples

Leaving the substrate blank wells empty, transfer 100 ul of the prepared standards and samples in duplicate into the appropriate wells (see recommended plate plan). Cover plate(s) with adhesive seal, gently agitate the micro-titer plate by tapping the edge of the plate for a few seconds to mix contents of each well and incubate for 1 hour at room temperature (18-25'C).

8. SECOND WASH STEP

Aspirate supernatant from wells and wash the microtiter plate (s) as described in point 6 above.

9. SECOND INCUBATION STEP biotinylated-IL-1B antibody

The kit contains one yellow-capped vial with concentrated IL-1B antibody-biotin conjugate.

Per microtiter plate, add 120 ul biotinylated IL-1B antibody to 12 ml working-strength dilution buffer just before use.

Leaving the substrate blank wells empty, add 100 ul of the biotinylated IL-1B antibody to all wells.

Cover plate(s) with adhesive seal, gently agitate the micro titer plate by tapping the edge of the plate for a few seconds to mix contents of each well and incubate for 1 hour at room temperature (18-25'C).

10.THIRD WASH STEP

Aspirate supernatant from wells and wash the microtiter plate(s) as described in point 6 above.

11.THIRD INCUBATION STEP Streptavidin-poly-HRP conjugate

The kit contains one brown vial of concentrated streptavidin- HRP conjugate, which must be stored at -18'C to -32'C to main-tain maximal stability. The contents of the vial will not be frozen at this temperature.

Per microtiter plate, add 3 ul streptavidine-poly-HRP conjugate to 30 ml of working-strength dilution buffer just before use. Do not prepare in advance of assay.

Leaving the substrate blank wells empty, add 100 ul of streptavidin-poly-HRP conjugate to all wells.

Cover the microtiter plate(s) with adhesive seal, gently agitate the microtiter plate by tapping the edge of the frame for a few seconds to mix contents of each well and incubate for 30 minutes at room temperature (18-25'C).


12. FOURTH WASH STEP

Aspirate supernatant from wells and wash the microtiter plate (s) as described in point 6 above.

13. FOURTH INCUBATION STEP Enzymatic colour development

Approximately 10 minutes before use, prepare the substrate solution as described on page 4 of this leaflet.

The substrate solution should be at room temperature (18-25'C) for optimal reproducible results. Add 100 ul of substrate solution to all wells, including the substrate blank wells.

Cover microtiter plate(s) with lid, gently agitate the microti-ter plate by tapping the edge of the frame for a few seconds to mix contents of each well and incubate for 30 minutes at room temperature (18-25'C) in the dark. Do not cover the plate with aluminium foil.

Note: the speed of enzymatic colour development is influenced by many factors including temperature and quality of the used TMB.

14. STOP ENZYMATIC REACTION

Add 100 ul of stop solution to all wells.

After stopping the colour is stable for maximally 30 minutes.

15. PLATE READ-OUT

Read at 450 nm in an ELISA reader.

IX. RESULTS

Substrate blank

- Record the absorbance at 450 nm for the substrate blank wells and average the duplicate values.

Standard curve

- Record the absorbance at 450 nm for each well containing stand-ard and average the duplicate values.

- Calculate the net average absorbances by subtracting the aver age of the substrate blank wells.

- Plot the net average absorbances (ordinate) versus the IL-10 concentration in pg/ml (abscissa) on log-linear paper and draw the best fitting curve. An example of a standard curve is given on the next page.

Samples

- Record the absorbance at 450 nm for each standard well, and a-verage the duplicate values.

- Calculate the net average absorbances by subtracting the aver-age of the substrate blank wells.

- Locate the net average absorbance value found for each sample on the vertical axis and follow a horizontal line intersecting the standard curve. At the point of intersection, read the IL- B conentration(pg/ml) from the horizontal axis. Multiply the obtained IL-1B concentration with the dilution factor of the sample and record this figure.

X. INCREASED SENSITIVITY

The assay sensitivity can be increased by a small adaptation of the incubation methodology. Just follow all the instructions as stated in the assay procedure (chapter VIII), but incubate at room temperature (18-25'C) on a horizontal plate shaker at 700 + 100 rpm. All incubations, including the enzymatic colour development, have to be completed on the shaker, in the same time as stated in the static assay procedure. This will result in an increase in assay sensitivity, without effects on the background levels (see figure next page).

SAMPLE DATA (DO NOT USE FOR CALCULATING ACTUAL RESULTS)

                        calculated mean absorbance at 450nm

 

static incubation

shaken incubation

substrate blank

0

0

  0         pg/ml

0.025

0.024

  0.4     pg/ml

0.076

0.029

  1.2      pg/ml

0.041

0.052

  3.7      pg/ml

0.083

0.125

 11   pg/ml

0.198

0.340

 33       pg/ml

0.582

1.033

100     pg/ml

1.558

2.582

300     pg/ml

2.777

>3.000

Do not use these data to construct a standard curve for sample value calculations.

For In Vitro Research Use Only-Not for use in Diagnostics


Return (Cytokine Kit information)

for recombinant cytokines and antibodies , click here

RDI Division of Fitzgerald Industries Intl

34 Junction Square Drive

Concord MA 01742-3049

USA

phone (978) 371-6446 or (800) 370-2222

fax      (978) 371-2266

EMAIL:antibodies@fitzgerald-fii.com

Return (Index/Home Page)